Non-ST Elevation Myocardial Infarction
25
5
7
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 25 trials
100.0%
+13.5% vs benchmark
20%
5 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (25)
Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study
Initial CT Perfusion-Guided Strategy for Suspected NSTEMI
Early Discharge Pathway Registry
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
FAMOUS-NSTEMI MRI Sub-Study
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI
Cardiac MRI Prior to Invasive Coronary Angiography in Patients With Suspected Non-ST-Elevation Myocardial Infarction
European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)
Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
Periodontal Disease, Inflammation and Acute Coronary Syndromes
Impact of Cardiac Rehabilitation Programs on Left Ventricular Remodeling After Acute Myocardial Infarction - the REHAB Trial
Multiomics and Imaging-based Assessment of Vulnerable Coronary Plaques in Acute Coronary Syndromes
the Invasive and Conservative Strategies in Elderly Frail Patients With Non-STEMI
PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions
A Polypill for Secondary Prevention of Ischemic Heart Disease
One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
EKG Criteria and Identification of Acute Coronary Occlusion
International Collaboration of Comprehensive Physiologic Assessment
Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients